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Although Lyme disease has been endemic to parts of the Lower Hudson Valley of New York, United 
States, for >2 decades, babesiosis has emerged there only since 2001. The number of Lower Hudson 
Valley residents in whom babesiosis was diagnosed increased 20-fold, from 6 to 119 cases per year 
during 2001–2008, compared with an ≈1.6-fold increase for the rest of New York. During 2002–2009, a 
total of 19 patients with babesiosis were hospitalized on 22 occasions at the regional tertiary care center. 
Concurrent conditions included advanced age, malignancies, splenectomy, and AIDS. Two patients 
acquired the infection from blood transfusions and 1 from perinatal exposure, rather than from a tick bite. 
One patient died. Clinicians should consider babesiosis in persons with fever and hemolytic anemia who 
have had tick exposure or have received blood products. 
Babesiosis is a tick-borne infection of erythrocytes. Babesia microti, the most common 
cause of babesiosis in North America, is transmitted by Ixodes scapularis ticks, which also 
transmits Borrelia burgdorferi, the cause of Lyme disease, and Anaplasma phagocytophilum, the 
cause of human granulocytic anaplasmosis (HGA) (1,2). Babesiosis, however, does not occur in 
all Lyme disease–endemic areas (1). Although Lyme disease has been highly endemic to parts of 
the Lower Hudson Valley (LHV) of New York in the United States since the mid-1980s, the first 
indigenous case of babesiosis did not occur there until 2001 (3). 
Page 2 of 11 
To better characterize the recent emergence of babesiosis in this region, we reviewed data 
for 2001–2008 on I. scapularis tick–transmitted infections in the 7 counties that make up the 
LHV. These counties are located immediately north of New York City. In addition, we reviewed 
the medical records of patients with babesiosis who were hospitalized during January 1, 2002–
December 31, 2009, at the Westchester Medical Center (WMC), the sole tertiary care medical 
center in the LHV. 
Methods 
Reported Babesiosis Cases in the LHV 
For this report, we defined the LHV as Westchester, Putnam, Dutchess, Orange, 
Rockland, Ulster, and Sullivan counties (4). Cases of babesiosis, Lyme disease, and HGA in this 
region were tabulated on the basis of statistics on reportable diseases available on the New York 
State Department of Health (NYSDOH) website (5). Cases listed as ehrlichiosis were assumed to 
be a surrogate for HGA in this region. For purposes of surveillance by the NYSDOH during the 
period reviewed, a diagnosis of babesiosis was considered confirmed when 1) a clinically 
compatible illness occurred in conjunction with identification of Babesia spp. parasites on blood 
smear or a positive immunoglobulin G (or total antibody) Babesia spp. serologic titer of >256 
(with testing confirmed by NYSDOH), or 2) in the absence of a clinically compatible illness, 
Babesia spp. parasites were present on blood smear (5). 
Patients Hospitalized with Babesiosis at WMC 
WMC is located in Valhalla, Westchester County, New York. We retrospectively 
reviewed medical records of patients with babesiosis documented by peripheral blood smear who 
were hospitalized at WMC during January 1, 2002–December 31, 2009. Case ascertainment was 
based on review of microbiology and infectious diseases records. For the 2 patients who had >1 
hospitalization for babesiosis, we included data for only the first hospitalization. Complete 
records were available for all but 1 patient; partial records were available for that patient. The 
Institutional Review Board at New York Medical College approved the medical records review. 
Statistical Methods 
Continuous variables were described with means and standard deviations. Categorical 
variables were described with frequencies and percentages, and differences were compared with 
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the Fisher exact test (2-tailed). Relative risk estimates over time and among counties were 
computed by using Poisson regression adjusting for population size. A p value <0.05 was 
considered significant. 
Results 
The LHV comprises 4 counties west of the Hudson River (Rockland, Orange, Sullivan, 
and Ulster) and 3 counties east of the Hudson River (Westchester, Putnam, and Dutchess) 
(Figure 1). Westchester County is located immediately north of the Bronx, New York. 
Babesiosis has been a reportable disease in New York since 1986. According to statistics 
compiled by NYSDOH (5), the number of cases of babesiosis diagnosed in residents of the 7-
county LHV increased nearly 20-fold from 6 per year to 119 per year during 2001–2008 (Figure 
2), with an average increase in incidence of 48.7% per year (95% confidence interval [CI] 
40.6%–57.2%) (Table 1) (5,6). In the rest of the state, the number of cases increased only ≈1.6-
fold during the same period (from 89 cases in 2001 to 142 cases in 2008) (5). 
Although the number of babesiosis cases increased on both sides of the river, 104 
(87.4%) of 119 reported cases in 2008 occurred in residents of counties east of the Hudson River 
(Table 1). The 104 cases in the 3 counties east of the Hudson River, with a total population of 
1,346,065 (6), corresponds to 7.7 cases per 100,000 residents, compared with 15 cases among a 
total population of 936,051 or 1.6 cases per 100,000 for the 4 counties west of the Hudson River 
(relative risk [RR] 4.82, 95% CI 2.79–8.92; p<0.001). In the 3 counties east of the river, 
Dutchess County accounted for 62 of the babesiosis cases in 2008 (21.2/100,000), Westchester 
County for 36 cases (3.8/100,000), and Putnam County for 6 cases (6.0/100,000); thus, the 
prevalence of babesiosis in 2008 was significantly greater for Dutchess County than for 
Westchester County (RR 5.61, 95% CI 3.72–8.46; p<0.001) or for Dutchess than for Putnam 
County (RR 3.53, 95% CI 1.51–8.09; p = 0.003). No significant difference was detected between 
Putnam and Westchester Counties (RR 1.60, 95% CI 0.68–3.81; p = 0.28) (5,6). 
For purposes of comparison, in 2001, a total of 2,584 Lyme disease cases were reported 
from the LHV, compared with 4,609 in 2008, representing a <2-fold increase; 78 ehrlichiosis 
(HGA) cases were reported in 2001, compared with 213 in 2008, a <3-fold increase (5). In 2008, 
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2,369 (51.4%) of the 4,609 reported Lyme disease cases occurred in residents of counties east of 
the Hudson River, compared with 186 (87.3%) of 213 reported ehrlichiosis (HGA) cases. 
Hospitalized Patients with Babesiosis 
Coincident with the emergence of babesiosis in the LHV, the number of patients 
hospitalized at WMC with this infection also markedly increased. Nineteen patients (18 adults) 
were hospitalized with babesiosis at WMC on 22 occasions from 2002 through 2009. All 19 
patients were residents of LHV; 15 (79%) resided in Westchester County, 2 in Dutchess County, 
and 1 each in Orange and Putnam Counties. 
The only child affected was a 6-week-old infant who acquired B. microti infection 
perinatally; a detailed case history for this patient will be reported elsewhere. For 2 of the 18 
cases in adults, transfusion of infected blood products was believed to have been the route of 
infection; 1 of these cases is described in more detail elsewhere (7). Fifteen (94%) of the 16 other 
adult patients had potential tick exposure in the LHV (tick exposure is defined as exposure to 
outdoor environments where ticks are likely to reside); for 10 (67%) of these patients, this was 
the only known tick exposure within 30 days before onset of symptoms. Of the 16, however, 
only 3 (19%) actually recalled a tick bite within this 30-day period. 
All 18 adult patients had a positive peripheral blood smear for Babesia spp. parasites 
(Table 2). Of the 8 patients who were tested for B. microti DNA by PCR, all had positive results. 
All but 2 of the patients were admitted during May–October. One patient was admitted in 
December, and the other was admitted in January. The patient who sought care in December had 
a tick bite 1 month before admission. Thirteen (72%) patients were men; the mean age was 54.1 
years (range 21–95 years). Mean time from onset of symptoms to diagnosis was 13.6 days 
(median 11 days, range 3–33 days). 
Five (28%) patients had had a splenectomy before the babesiosis diagnosis, 2 (11%) had 
AIDS, and 5 (28%) had malignancies (2 of whom were among the 5 patients who had 
splenectomies). Of the 5 patients with malignancies, 1 had acute myelogenous leukemia and had 
received a stem cell bone marrow transplant, 2 patients had B-cell follicular lymphoma (and had 
been treated with rituximab), 1 had a teratoma, and 1 had renal cell carcinoma. Of the 8 patients 
<50 years of age, 5 (63%) were potentially immunocompromised because of malignancy, 
splenectomy, or AIDS. 
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Common symptoms or signs were fever (temperature >38°C) (83%), headache (39%), 
malaise (33%), and chills (28%); splenomegaly was present in 2 (15%) of the 13 patients with an 
intact spleen. Frequent laboratory findings included anemia, thrombocytopenia, and abnormal 
liver function tests (Table 2). All 15 patients for whom a lactate dehydrogenase level was 
available had a value above the upper reference limit (221 U/L). Reticulocytes varied from 1.1% 
to 19.9% in 12 patients (median 3.1%; reference 0.5%–1.5%). Haptoglobin level was <20 mg/dL 
in all 10 patients who were tested (reference 26–85 mg/dL). 
Eleven patients were treated with azithromycin and atovaquone; a rash to azithromycin 
developed in 1 patient, and the drug regimen was changed to clindamycin and atovaquone. In 
another patient, a rash to atovaquone developed, and clindamycin and quinine was prescribed. 
Six patients were initially treated with clindamycin and quinine; adverse reactions to quinine 
developed in 3. In 1 patient, QT prolongation developed, and in 2 patients, hearing loss 
developed. One patient was initially treated with clindamycin and atovaquone. Eight (44%) 
patients required blood transfusion for anemia, and 3 (17%) received erythrocyte exchange as 
adjunctive therapy. 
Length of hospital stay ranged from 3 to 73 days (median 8 days). One patient had left 
upper quadrant pain and splenic rupture and was treated conservatively without surgery. The 1 
death occurred in a 95-year-old patient in whom shock and respiratory failure developed and 
who required admission to the intensive care unit. Another patient required ventilator support. In 
15 (83%) patients, infection resolved with a single course of antimicrobial drugs. Illness recurred 
in 2 patients but resolved after a subsequent and more prolonged course of antimicrobial drug 
treatment (the 2 latter patients have been included in previous reports [7–9]). 
Discussion 
As of 2008, babesiosis cases in residents of the LHV accounted for 45.6% of the 261 
cases reported in New York (5). Testing of selected I. scapularis ticks by PCR in 2002 showed 
positive results for B. microti in tick pools collected in Dutchess and Westchester Counties (5). A 
more recent study of 154 adult I. scapularis ticks collected in 2008 from 2 locations in 
Westchester County identified 24 (15.6%) ticks that were infected with B. microti according to 
PCR, compared with 34 (25.8%) of 132 adult ticks collected from 3 locations in Suffolk County, 
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in Long Island, New York (p<0.04) (10); babesiosis has been indigenous to Suffolk County since 
1975, with 95 cases reported there in 2008 alone (5). These infection rates, however, should be 
interpreted cautiously because an unknown proportion of positive findings may have resulted 
from detection of B. odocoilei in the ticks evaluated, rather than B. microti. B. odocoilei, which is 
not regarded as a human pathogen, infects deer ticks more frequently than does B. microti in sites 
where these piroplasms coexist (11). 
There are 2 prior reports of hospitalized patients in New York with babesiosis. One report 
published in 1998 described 139 adults with babesiosis hospitalized during 1982–1993 (12). 
More than 90% of these patients resided in Suffolk County; only 2 resided in Westchester 
County. The other report, published in 2001, described 34 adults and children with babesiosis 
hospitalized at 2 tertiary care centers in Suffolk County (13). The latter patients were 
hospitalized over 13 consecutive years, but the exact years were not specified. The general 
clinical and laboratory features of babesiosis in these 2 case series were similar to those observed 
in the patients in our study. Most patients had a nonspecific febrile illness associated with 
hemolytic anemia, thrombocytopenia, and abnormal liver function test results. Of the 139 
patients in the 1998 series, 16 (11.7%) had had a splenectomy (12), as did 8 (27%) of the 30 
adults in the 2001 report (13), but in neither of the 2 earlier reports were any patients identified 
as having lymphoma and receiving treatment with rituximab (9), receiving a transplantation, or 
having AIDS. Thus, our case series presumably included more patients now recognized to be at 
high risk for relapse of infection (9). The 5.6% case-fatality rate in our study, however, is slightly 
lower than the 6.5% in the 1998 report (12) and the 8.8% in the 2001 report (13). Unlike the 2 
prior case series, 2 (11%) of the patients in our study were believed to have been infected 
through receipt of an infected blood product (7), which provides further evidence of the growing 
importance of this route of transmission (14–18). 
Six (33%) of the patients reported here had serologic evidence of Lyme disease, but this 
finding may overestimate the frequency of coinfection because only 1 had an objective clinical 
manifestation of Lyme disease (erythema migrans). Among the adult ticks collected in 
Westchester County in 2008 (10), 79.2% of those infected with Babesia spp. were also infected 
with B. burgdorferi, which reinforces the need to consider the possibility of concomitant Lyme 
disease in patients from the LHV in whom babesiosis is diagnosed. 
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How B. microti found its way from areas to which this microorganism is endemic into the 
I. scapularis tick population of the LHV is unclear. Evidence suggests that babesiosis is also 
emerging as a human pathogen in contiguous geographic areas of western Connecticut (19,20). 
The principal animal reservoir for B. microti is the white-footed mouse, Peromyscus leucopus 
(1). Other reservoirs include voles and shrews. These animals are not likely to travel great 
distances, which suggests that movement of these animals is an unlikely explanation for the 
emergence of babesiosis in the LHV. 
Babesiosis is an emerging infectious disease in the LHV of New York with the potential 
to cause serious illness and death, especially in highly immunocompromised patients. Clinicians 
should consider this diagnosis in persons with fever and hemolytic anemia who have been 
exposed to ticks or have received blood products. 
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Table 1. Babesiosis cases reported to the New York State Department of Health, Lower Hudson Valley, New York, USA, 2001–2008 
Area (2008 population) 2001 2002 2003 2004 2005 2006 2007 2008 
West of Hudson River (936,051) 0 0 1 2 5 7 5 15 
 Rockland County (298,545) 0 0 0 1 0 2 0 3 
 Orange County (379,647) 0 0 1 1 1 5 5 7 
 Sullivan County (76,189) 0 0 0 0 1 0 0 1 
 Ulster County (181,670) 0 0 0 0 3 0 0 4 
East of Hudson River (1,346,065) 6 8 20 16 38 70 74 104 
 Dutchess County (292,878) 2 4 6 7 23 42 44 62 
 Putnam County (99,244) 1 0 1 0 2 3 1 6 
 Westchester County (953,943) 3 4 13 9 13 25 29 36 
 
Page 10 of 11 
 
Table 2. Selected demographic and clinical features and laboratory test results for 18 adults with babesiosis hospitalized at 
Westchester Medical Center, Valhalla, New York, USA, 2001–2008* 
Characteristic Value 
Mean age, y, ± SD (range) 54.1 ± 20.1 (21–95) 
Male, no. (%) 13 (72.2) 
Mean time from symptom onset to diagnosis, d, ± SD (range) 13.6 ± 9.28 (3–33) 
Recollection of tick bite within 30 d, no. (%) 3 (18.8) 
Temperature >38°C, no. (%) 15 (83.3) 
Splenomegaly, no. (%), n = 13 2 (15.4) 
Mean initial parasitemia, %, ± SD (range), n = 17† 4.49 ± 4.57 (0.01–14) 
Mean highest level of parasitemia, %, ± SD (range), n = 17† 5.34 ± 5.79 (0.05–18) 
Mean initial lymphocyte count × 109/L,± SD (range), n = 17 7.2 ± 3.38 (3.2–15.4) 
Lymphocyte count <1,000 ×106/L, no. (%), n = 12 5 (41.6) 
Mean hemoglobin minimum, g/dL,± SD (range) 8.2 ± 1.98 (3.5–11.1) 
Mean platelets minimum, × 109/L, ± SD (range) 110.8 ± 139.2 (19–615) 
Platelets minimum <150 × 109/L, no. (%) 16 (88.9) 
Mean initial erythrocyte sedimentation rate, mm/h,± SD (range), n = 9 76.7 ± 33.3 (32–138) 
Mean initial lactate dehydrogenase, U/L, ± SD (range), n = 15 931.5 ± 562 (229–2074) 
Mean initial aspartate aminotransferase, U/L, ± SD (range) 237.7 ± 366.9 (19–1450) 
Initial aspartate aminotransferase >30 U/L, no. (%) 14 (77.8) 
Mean initial alanine aminotransferase, U/L, ± SD (range) 110.2 ± 111 (16–433) 
Initial alanine aminotransferase >40 U/L, no. (%) 13 (72.2) 
Mean initial total bilirubin, mg/dL, ± SD (range) 3.4 ± 5.59 (0.4–24.6) 
Initial total bilirubin >1.2 mg/dL, no. (%) 10 (55.6) 
Mean serum sodium minimum, meq/L, ± SD (range), n = 17 127.6 ± 10.1 (94–139) 
Mean creatinine maximum , ng/mL, ± SD (range), n = 17 1.3 ± 0.59 (0.7–2.7) 
*Data were obtained from all 18 patients unless otherwise indicated. 
†For 1 patient with a positive smear, the level of parasitemia is unknown. 
 
Figure 1. Map of the Lower Hudson Valley 
of New York, USA. Westchester, Putnam, 
and Dutchess Counties are east of the 
Hudson River, and Orange, Rockland, 
Ulster and Sullivan Counties are west of 
the Hudson River. The star indicates the 
site of the Westchester Medical Center. 
Permission for use of this image granted 
from the Westchester Institute for Human 
Development on July 23, 2010. 
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Figure 2. Annual number of reported babesiosis cases, Lower Hudson Valley, New York, USA, 2001–
2008. 
